Claro Advisors’s Core Laboratories CLB Stock Holding History

Claro Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-62	Closed	-$7K	–	286
2018 Q4	$7K	Buy	+62	New	+$5.35K	0.01%	732

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Claro Advisors's CLB Position: Q1 2019 in Review

Claro Advisors sold out of Core Laboratories (CLB) in Q1 2019, closing a stake of 62 shares — an estimated $7K sold.

Claro Advisors first reported a position in CLB in Q4 2018 and held it in 1 quarter. The position peaked at $7K in Q4 2018. 313 funds tracked by Wall St. Rank hold CLB as of Q1 2019.

Claro Advisors reported no remaining Core Laboratories position as of Q1 2019 after selling out during the quarter.
Claro Advisors sold 62 Core Laboratories shares in Q1 2019, an estimated $7K.
Claro Advisors first reported a position in Core Laboratories in Q4 2018 and held it in 1 quarter.
Claro Advisors's Core Laboratories position peaked at $7K in Q4 2018.
313 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2019.

Based on Claro Advisors's 13F filing for Q1 2019, filed 10 May 2019.